Literature DB >> 18491867

Linear and cyclic peptides from the entomopathogenic bacterium Xenorhabdus nematophilus.

Gerhard Lang1, Tim Kalvelage, Arne Peters, Jutta Wiese, Johannes F Imhoff.   

Abstract

Three new peptides, xenortides A and B and xenematide, were isolated from a culture of the nematode-associated entomopathogenic bacterium Xenorhabdus nematophilus. Their structures were elucidated using NMR, MS, and chemical derivatization methods. Xenortides A and B are the N-phenethylamide and tryptamide derivatives, respectively, of the dipeptide (NMe-L-Leu-NMe-L-Phe). The cyclodepsipeptide xenematide has the sequence (Thr-Trp-Trp-Gly), with a 2-phenylacetamide substituent at the threonine residue and one d-tryptophan. The new peptides and the two known compounds xenocoumacin II and nematophin were tested for antibacterial, antifungal, insecticidal, and anti-Artemia salina activities. Xenematide and xenocoumacin II showed moderate antibacterial activities. Xenocoumacin II, nematophin, and the two xenortides were active in the Artemia salina assay, and xenematide acted weakly insecticidal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18491867     DOI: 10.1021/np800053n

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  32 in total

1.  Role of secondary metabolites in establishment of the mutualistic partnership between Xenorhabdus nematophila and the entomopathogenic nematode Steinernema carpocapsae.

Authors:  Swati Singh; David Orr; Emmanuel Divinagracia; Joseph McGraw; Kellen Dorff; Steven Forst
Journal:  Appl Environ Microbiol       Date:  2014-11-14       Impact factor: 4.792

2.  An unbiased method for clustering bacterial effectors using host cellular phenotypes.

Authors:  Andrea J Dowling; David J Hodgson
Journal:  Appl Environ Microbiol       Date:  2013-12-02       Impact factor: 4.792

Review 3.  Merging chemical ecology with bacterial genome mining for secondary metabolite discovery.

Authors:  Maria I Vizcaino; Xun Guo; Jason M Crawford
Journal:  J Ind Microbiol Biotechnol       Date:  2013-10-15       Impact factor: 3.346

4.  A natural prodrug activation mechanism in nonribosomal peptide synthesis.

Authors:  Daniela Reimer; Klaas M Pos; Marco Thines; Peter Grün; Helge B Bode
Journal:  Nat Chem Biol       Date:  2011-09-18       Impact factor: 15.040

Review 5.  Countercurrent Separation of Natural Products: An Update.

Authors:  J Brent Friesen; James B McAlpine; Shao-Nong Chen; Guido F Pauli
Journal:  J Nat Prod       Date:  2015-07-15       Impact factor: 4.050

6.  Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine.

Authors:  Brianna B Williams; Andrew H Van Benschoten; Peter Cimermancic; Mohamed S Donia; Michael Zimmermann; Mao Taketani; Atsushi Ishihara; Purna C Kashyap; James S Fraser; Michael A Fischbach
Journal:  Cell Host Microbe       Date:  2014-09-25       Impact factor: 21.023

7.  Regulating alternative lifestyles in entomopathogenic bacteria.

Authors:  Jason M Crawford; Renee Kontnik; Jon Clardy
Journal:  Curr Biol       Date:  2010-01-12       Impact factor: 10.834

8.  Identification of Cyclic Depsipeptides and Their Dedicated Synthetase from Hapsidospora irregularis.

Authors:  Shuwei Zhang; Yixing Qiu; Thomas B Kakule; Zhenyu Lu; Fuchao Xu; John G Lamb; Christopher A Reilly; Yong Zheng; Shing Wo Simon Sham; Wei Wang; Lijiang Xuan; Eric W Schmidt; Jixun Zhan
Journal:  J Nat Prod       Date:  2017-01-20       Impact factor: 4.050

9.  Isolation of proline-based cyclic dipeptides from Bacillus sp. N strain associated with rhabditid [corrected] entomopathogenic nematode and its antimicrobial properties.

Authors:  Nishanth Kumar; C Mohandas; Bala Nambisan; D R Soban Kumar; Ravi S Lankalapalli
Journal:  World J Microbiol Biotechnol       Date:  2012-10-12       Impact factor: 3.312

Review 10.  Role of Proline in Pathogen and Host Interactions.

Authors:  Shelbi L Christgen; Donald F Becker
Journal:  Antioxid Redox Signal       Date:  2018-02-02       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.